EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1

Heng Du, Yu Chi Yang, Heng-Jia Liu, Min Yuan, John M Asara, Kwok-Kin Wong, Elizabeth P Henske, Mallika Singh, David J Kwiatkowski

Journal of Clinical Investigation · 01.11.2023 · 133 (21)

DOI: 10.1172/jci167861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.11.2023. Verfasst von Heng Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: MTOR Inhibitors, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH, Revolution Medicines Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PI3K/AKT/mTOR pathway is commonly dysregulated in cancer. Rapalogs exhibit modest clinical benefit, likely owing to their lack of effects on 4EBP1. We hypothesized that bi-steric mTORC1-selective inhibitors would have greater potential for clinical benefit than rapalogs in tumors with mTORC1 dysfunction. We assessed this hypothesis in tumor models with high mTORC1 activity both in vitro and in vivo. Bi-steric inhibitors had strong growth inhibition, eliminated phosphorylated 4EBP1, and induced more apoptosis than rapamycin or MLN0128. Multiomics analysis showed extensive effects of the bi-steric inhibitors in comparison with rapamycin. De novo purine synthesis was selectively inhibited by bi-sterics through reduction in JUN and its downstream target PRPS1 and appeared to be the cause of apoptosis. Hence, bi-steric mTORC1-selective inhibitors are a therapeutic strategy to treat tumors driven by mTORC1 hyperactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MTOR InhibitorsPhosphatidylinositol 3-KinasesMechanistic Target of Rapamycin Complex 1Cell Line, TumorSirolimusApoptosisCell ProliferationProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

CancerOncologyTherapeutics

Substanzen

Mechanistic Target of Rapamycin Complex 1MTOR InhibitorsPhosphatidylinositol 3-KinasesSirolimusProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Biology, Revolution Medicines Inc., Redwood City, California, USA.
  • Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York, USA.
  • Division of Hematology and Medical Oncology, Department of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York University Langone Health, New York, New York, USA.

Förderung

  • NCI NIH HHS
  • NIH
  • Revolution Medicines Inc

Zitieren

APA

Du, H., Yang, Y. C., Liu, H. J., Yuan, M., Asara, J. M., Wong, K. K., Henske, E. P., Singh, M., & Kwiatkowski, D. J. (2023). Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1. Journal of Clinical Investigation, 133(21). https://doi.org/10.1172/jci167861

Vancouver

Du H, Yang YC, Liu HJ, Yuan M, Asara JM, Wong KK, et al. Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1. Journal of Clinical Investigation. 2023;133(21). doi:10.1172/jci167861

BibTeX
@article{Du2023,
  author = {Du, Heng and Yang, Yu Chi and Liu, Heng-Jia and Yuan, Min and Asara, John M and Wong, Kwok-Kin and Henske, Elizabeth P and Singh, Mallika and Kwiatkowski, David J},
  title = {Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {21},
  doi = {10.1172/jci167861}
}
Kostenlos starten →